 CARLSBAD, Calif., March 09, 2021 GLOBE NEWSWIRE -- Qualigen Therapeutics, Inc. Nasdaq: QLGN, a biotechnology company focused on developing novel therapeutics for the treatment of cancer and infectious diseases, announced today that it has promoted long-time officer Shishir Sinha to the newly created position of Chief Operating Officer. Mr. Sinha is based in Qualigens corporate headquarters in Carlsbad, California. 